HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
34.71 USD
+1.09 (+3.24%)
34.975 USD
+0.27 (+0.76%)
Overall HIMS gets a fundamental rating of 5 out of 10. We evaluated HIMS against 100 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of HIMS get a neutral evaluation. Nothing too spectacular is happening here. HIMS shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
HIMS had a positive operating cash flow in the past year.
HIMS had negative earnings in 4 of the past 5 years.
In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
HIMS has a better Return On Assets (5.99%) than 83.00% of its industry peers.
The Return On Equity of HIMS (23.03%) is better than 91.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.84%, HIMS is in the better half of the industry, outperforming 62.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 6.05%, HIMS belongs to the top of the industry, outperforming 81.00% of the companies in the same industry.
HIMS has a better Operating Margin (5.96%) than 63.00% of its industry peers.
Looking at the Gross Margin, with a value of 75.01%, HIMS belongs to the top of the industry, outperforming 89.00% of the companies in the same industry.
In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for HIMS has been increased compared to 1 year ago.
The number of shares outstanding for HIMS has been increased compared to 5 years ago.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 4.07 indicates that HIMS is not in any danger for bankruptcy at the moment.
HIMS has a better Altman-Z score (4.07) than 76.00% of its industry peers.
HIMS has a debt to FCF ratio of 8.13. This is a slightly negative value and a sign of low solvency as HIMS would need 8.13 years to pay back of all of its debts.
With a Debt to FCF ratio value of 8.13, HIMS perfoms like the industry average, outperforming 54.00% of the companies in the same industry.
HIMS has a Debt/Equity ratio of 1.67. This is a high value indicating a heavy dependency on external financing.
HIMS has a Debt to Equity ratio of 1.67. This is in the lower half of the industry: HIMS underperforms 71.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 4.07 |
ROIC/WACC0.65
WACC8.99%
2.3 Liquidity
HIMS has a Current Ratio of 1.88. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.88, HIMS is doing good in the industry, outperforming 73.00% of the companies in the same industry.
HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.64, HIMS is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.73%, which is quite impressive.
Measured over the past years, HIMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.35% on average per year.
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.02%.
HIMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.77% yearly.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.75% yearly.
The Revenue is expected to grow by 22.53% on average over the next years. This is a very strong growth
EPS Next Y11.88%
EPS Next 2Y22.49%
EPS Next 3Y23.43%
EPS Next 5Y41.75%
Revenue Next Year59.73%
Revenue Next 2Y38.12%
Revenue Next 3Y31.11%
Revenue Next 5Y22.53%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 64.28 indicates a quite expensive valuation of HIMS.
The rest of the industry has a similar Price/Earnings ratio as HIMS.
HIMS is valuated expensively when we compare the Price/Earnings ratio to 25.45, which is the current average of the S&P500 Index.
HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 42.84.
HIMS's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 34.46. HIMS is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.28 | ||
| Fwd PE | 42.84 |
4.2 Price Multiples
HIMS's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as HIMS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 65.66 | ||
| EV/EBITDA | 43.93 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HIMS does not grow enough to justify the current Price/Earnings ratio.
HIMS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 23.43% in the coming years.
PEG (NY)5.41
PEG (5Y)1.07
EPS Next 2Y22.49%
EPS Next 3Y23.43%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
34.71
+1.09 (+3.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.61%
Inst Owner Change15.67%
Ins Owners10.28%
Ins Owner Change-2.17%
Market Cap7.85B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target49.8 (43.47%)
Short Float %34.56%
Short Ratio2.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)0%
PT rev (3m)-3.07%
EPS NQ rev (1m)-50.06%
EPS NQ rev (3m)-53.71%
EPS NY rev (1m)-2.1%
EPS NY rev (3m)-11.33%
Revenue NQ rev (1m)-1.58%
Revenue NQ rev (3m)-2.15%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.28 | ||
| Fwd PE | 42.84 | ||
| P/S | 3.55 | ||
| P/FCF | 65.66 | ||
| P/OCF | 24.13 | ||
| P/B | 13.5 | ||
| P/tB | 61.86 | ||
| EV/EBITDA | 43.93 |
EPS(TTM)0.54
EY1.56%
EPS(NY)0.81
Fwd EY2.33%
FCF(TTM)0.53
FCFY1.52%
OCF(TTM)1.44
OCFY4.14%
SpS9.78
BVpS2.57
TBVpS0.56
PEG (NY)5.41
PEG (5Y)1.07
Graham Number5.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 4.07 |
F-Score3
WACC8.99%
ROIC/WACC0.65
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y11.88%
EPS Next 2Y22.49%
EPS Next 3Y23.43%
EPS Next 5Y41.75%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year59.73%
Revenue Next 2Y38.12%
Revenue Next 3Y31.11%
Revenue Next 5Y22.53%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year358.46%
EBIT Next 3Y94.49%
EBIT Next 5Y61.52%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status for HIMS stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HIMS & HERS HEALTH INC?
The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to grow by 11.88% in the next year.